Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
Int J Mol Sci. 2020 Jan 14;21(2):524. doi: 10.3390/ijms21020524.
Idiopathic pulmonary fibrosis (IPF) is a progressive chronic disease characterized by excessing scarring of the lungs leading to irreversible decline in lung function. The aetiology and pathogenesis of the disease are still unclear, although lung fibroblast and epithelial cell activation, as well as the secretion of fibrotic and inflammatory mediators, have been strongly associated with the development and progression of IPF. Significantly, long non-coding RNAs (lncRNAs) are emerging as modulators of multiple biological processes, although their function and mechanism of action in IPF is poorly understood. LncRNAs have been shown to be important regulators of several diseases and their aberrant expression has been linked to the pathophysiology of fibrosis including IPF. This review will provide an overview of this emerging role of lncRNAs in the development of IPF.
特发性肺纤维化(IPF)是一种进行性慢性疾病,其特征是肺部过度瘢痕形成,导致肺功能不可逆转下降。尽管肺成纤维细胞和上皮细胞的激活以及纤维化和炎症介质的分泌与 IPF 的发展和进展密切相关,但该疾病的病因和发病机制仍不清楚。重要的是,长链非编码 RNA(lncRNA)作为多种生物学过程的调节剂而出现,尽管它们在 IPF 中的功能和作用机制仍知之甚少。lncRNA 已被证明是几种疾病的重要调节剂,其异常表达与包括 IPF 在内的纤维化的病理生理学有关。这篇综述将概述 lncRNA 在 IPF 发展中的这一新兴作用。